$SBIG
springbig Holdings Inc

2024 Q3 Form 10-Q Financial Statement

#000121390024068301 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $6.612M
YoY Change -8.34%
Cost Of Revenue $1.915M
YoY Change 26.74%
Gross Profit $4.697M
YoY Change -17.64%
Gross Profit Margin 71.04%
Selling, General & Admin $3.484M
YoY Change -35.85%
% of Gross Profit 74.18%
Research & Development $1.270M
YoY Change -37.9%
% of Gross Profit 27.04%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.754M
YoY Change -36.41%
Operating Profit -$57.00K
YoY Change -96.79%
Interest Expense $544.0K
YoY Change -270.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$647.0K
YoY Change -68.13%
Income Tax
% Of Pretax Income
Net Earnings -$647.0K
YoY Change -68.1%
Net Earnings / Revenue -9.79%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 46.32M shares 45.59M shares
Diluted Shares Outstanding 45.72M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $700.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $3.223M
Other Receivables
Total Short-Term Assets $4.724M
YoY Change -28.56%
LONG-TERM ASSETS
Property, Plant & Equipment $282.0K
YoY Change -14.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.223M
YoY Change 163.53%
TOTAL ASSETS
Total Short-Term Assets $4.724M
Total Long-Term Assets $3.223M
Total Assets $7.947M
YoY Change 1.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.602M
YoY Change -35.06%
Accrued Expenses
YoY Change
Deferred Revenue $1.751M
YoY Change 714.42%
Short-Term Debt $510.0K
YoY Change
Long-Term Debt Due $7.391M
YoY Change 320.9%
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $13.64M
YoY Change 381.84%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $13.64M
YoY Change 287.39%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities $13.64M
Total Liabilities $16.42M
YoY Change 43.04%
SHAREHOLDERS EQUITY
Retained Earnings -$36.80M
YoY Change 20.26%
Common Stock $4.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.472M
YoY Change
Total Liabilities & Shareholders Equity $7.947M
YoY Change 1.42%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$647.0K
YoY Change -68.1%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40049
dei Entity Registrant Name
EntityRegistrantName
SPRINGBIG HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-2789488
dei Entity Address Address Line1
EntityAddressAddressLine1
621 NW 53rd Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 500
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33487
dei City Area Code
CityAreaCode
(800)
dei Local Phone Number
LocalPhoneNumber
772-9172
dei Security12b Title
Security12bTitle
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46315018 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
724000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
331000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1737000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1595000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3223000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2948000 usd
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
252000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
273000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
525000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
893000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
4724000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4445000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2941000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
282000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
320000 usd
CY2024Q2 us-gaap Assets
Assets
7947000 usd
CY2023Q4 us-gaap Assets
Assets
5105000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1602000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2925000 usd
CY2024Q2 sbig Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
2041000 usd
CY2023Q4 sbig Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
1951000 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
510000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1925000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
7391000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4360000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1751000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1751000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
341000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
99000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13636000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13551000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2729000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
225000 usd
CY2024Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
54000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
16419000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
13779000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46148026 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46148026 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45339762 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45339762 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28319000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27887000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36795000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36565000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-8472000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8674000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7947000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5105000 usd
CY2024Q2 us-gaap Revenues
Revenues
6612000 usd
CY2023Q2 us-gaap Revenues
Revenues
7214000 usd
us-gaap Revenues
Revenues
13086000 usd
us-gaap Revenues
Revenues
14371000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
1915000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1511000 usd
us-gaap Cost Of Revenue
CostOfRevenue
3709000 usd
us-gaap Cost Of Revenue
CostOfRevenue
2861000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
4697000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
5703000 usd
us-gaap Gross Profit
GrossProfit
9377000 usd
us-gaap Gross Profit
GrossProfit
11510000 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1127000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2186000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2654000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4664000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1270000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2045000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2936000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4345000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2357000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3245000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4126000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6002000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
4754000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
7476000 usd
us-gaap Operating Expenses
OperatingExpenses
9716000 usd
us-gaap Operating Expenses
OperatingExpenses
15011000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-57000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1773000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-339000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3501000 usd
CY2024Q2 us-gaap Interest Income Operating
InterestIncomeOperating
2000 usd
CY2023Q2 us-gaap Interest Income Operating
InterestIncomeOperating
4000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
6000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
14000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
544000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
323000 usd
us-gaap Interest Expense
InterestExpense
1419000 usd
us-gaap Interest Expense
InterestExpense
714000 usd
us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
1573000 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
48000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-64000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
51000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
89000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-647000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2028000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-230000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4290000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-647000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2028000 usd
us-gaap Net Income Loss
NetIncomeLoss
-230000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4290000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45721610 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31489803 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45576941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29159766 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-8025000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
200000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-647000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-8472000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8674000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
395000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37000 usd
us-gaap Net Income Loss
NetIncomeLoss
-230000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-8472000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5615000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
205000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
161000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2384000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1250000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2028000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3643000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3628000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
367000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
274000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2384000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1250000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4290000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3643000 usd
us-gaap Net Income Loss
NetIncomeLoss
-230000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4290000 usd
us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
1573000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
108000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
101000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
131000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
482000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
203000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
395000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
367000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
167000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
380000 usd
sbig Accrued Interest On Convertible Notes
AccruedInterestOnConvertibleNotes
293000 usd
sbig Accrued Interest On Convertible Notes
AccruedInterestOnConvertibleNotes
-10000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
180000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
121000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
51000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
89000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
442000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1493000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-368000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
68000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-21000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-21000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1528000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
471000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-35000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-130000 usd
sbig Increase Decrease In Contract With Customer Liability Payroll Tax Credits
IncreaseDecreaseInContractWithCustomerLiabilityPayrollTaxCredits
1442000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-76000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1919000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2563000 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
6000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
63000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
84000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-90000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6400000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2895000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2913000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
1600000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1415000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
540000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
775000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2661000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
189000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
274000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2375000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-167000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
393000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2820000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
331000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3546000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
724000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726000 usd
us-gaap Interest Paid Net
InterestPaidNet
847000 usd
us-gaap Interest Paid Net
InterestPaidNet
248000 usd
us-gaap Stock Issued1
StockIssued1
37000 usd
us-gaap Notes Issued1
NotesIssued1
342000 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
88000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2781000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
165000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1250000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – DESCRIPTION OF BUSINESS</b></span></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SpringBig Holdings, Inc. and its wholly owned subsidiaries (the “Company,” “we,” “us,”, “our”, or “SpringBig”) developed a software platform that provides marketing and customer engagement services to cannabis dispensaries and brands throughout the United States and Canada. The Company allows merchants to provide loyalty plans and rewards directly to consumers through an internet portal and mobile applications. Our operational headquarters are in Boca Raton, Florida, with additional offices located in the United States and Canada.</span></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has one direct wholly owned subsidiary, SpringBig, Inc.</span></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 14, 2022 (the “Closing Date”), SpringBig Holdings, Inc. (formerly known as Tuatara Capital Acquisition Corporation (“Tuatara” or “TCAC”)), consummated the business combination of SpringBig, Inc. (“Legacy SpringBig”) and HighJump Merger Sub, Inc., the wholly-owned subsidiary of Tuatara, pursuant to the Amended and Restated Agreement of Plan Merger, dated as of April 14, 2022, as amended, by and among Tuatara, HighJump Merger Sub, Inc. and Legacy SpringBig. Prior to the closing of the business combination (the “Closing”), Tuatara changed its jurisdiction of incorporation by deregistering as a Cayman Islands exempted company and continuing and domesticating as a corporation incorporated under the laws of the State of Delaware. In connection with the Closing, the registrant changed its name from Tuatara Capital Acquisition Corporation to “SpringBig Holdings, Inc.” SpringBig will continue the existing business operations of Legacy SpringBig as a publicly traded company.</span></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning June 15, 2022, the ticker symbols for the Company’s common stock and publicly traded warrants were changed to “SBIG” and “SBIGW,” respectively, and commenced trading on The Nasdaq Capital Market.</span></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 1, 2023, the Board of Directors of SpringBig Holdings, Inc. determined that it would not be in the best interest of the Company or its shareholders to meet the continued listing requirements of the Nasdaq Capital Market, and the Company notified the Nasdaq Stock Market LLC (“Nasdaq”) that it was withdrawing its appeal of the Nasdaq Listings Qualification staff’s delist determination dated March 7, 2023, for the Company’s failure to meet the market value of listed securities requirement in the Nasdaq Listing Rules.</span></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s common stock is now quoted for trading on the OTCQX® Best Market and its public warrants are now quoted for trading on the OTC Pink Market under their current trading symbols “SBIG” and “SBIGW,” respectively. The Company’s common stock started trading on the OTCQX® Best Market on September 6, 2023. The Company remains a reporting company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).</span></p>
CY2024Q2 sbig Number Of Subsidiaries
NumberOfSubsidiaries
1 pure
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36800000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1900000 usd
CY2024Q2 sbig Working Capital
WorkingCapital
8900000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
700000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration:underline">Use of Estimates</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Certain accounting policies involve a “critical accounting estimate” because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. In addition, while the Company have used best estimates based on facts and circumstances available to us at the time, different acceptable assumptions would yield different results. Changes in the accounting estimates are reasonably likely to occur from period to period, which may have a material impact on the presentation of our financial condition and results of operations. The Company reviews these estimates and assumptions periodically and reflects on the effects of revisions in the period that are determined to be necessary. We believe that the assumptions and estimates associated with income taxes, equity-based compensation (including issuance of common stock for services rendered), warrants and allowance for credit losses have the greatest potential impact on our consolidated financial statements. Therefore, the Company consider the policies related to these financial areas to be critical accounting policies.</span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. Accounting estimates used in the preparation of these financial statements change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. Actual results may differ materially from these estimates.</span></p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration:underline">Concentrations of Credit Risk</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject us to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with high credit-quality financial institutions. Such deposits may be in excess of federally insured limits. To date, we have not experienced any losses on our cash and cash equivalents. We perform periodic evaluations of the relative credit standing of the financial institutions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We perform ongoing credit evaluations of our customers’ financial condition and require no collateral from our customers. We maintain a credit loss reserve for expected credit losses based upon the expected collectability of accounts receivable balances. See <i>Effective Accounting Pronouncements</i> within this Note below for further information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We had one customer representing 14% of our total revenues for the six months ended June 30, 2024, and the same customer represented more than 12% of total revenues for the six months ended June 30, 2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">At June 30, 2024, we had two customers representing 32% of accounts receivable and the same two customers represented 30% of accounts receivable at December 31, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We had one vendor representing 89% of cost of goods sold for the six months ended June 30, 2024, and the same vendor represented 80% of cost of goods sold for the six months ended June 30, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We had one vendor representing 32% of accounts payable as of June 30, 2024. At December 31, 2023, two vendors represented 30% of accounts payable.</span></p>
CY2024Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
250000 usd
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
200000 usd
CY2024Q2 us-gaap Billed Contract Receivables
BilledContractReceivables
3988000 usd
CY2023Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
3690000 usd
CY2024Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
972000 usd
CY2023Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
853000 usd
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4960000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4543000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1737000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1595000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3223000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2948000 usd
CY2024Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
80000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
231000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
167000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
380000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1595000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
167000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
25000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1737000 usd
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
102000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
379000 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
334000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
425000 usd
CY2024Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
89000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
89000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
525000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
893000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1112000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1048000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
830000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
728000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
282000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
320000 usd
CY2024Q2 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
47000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
101000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
131000 usd
CY2023Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
0 usd
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
302000 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
393000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
38000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
176000 usd
CY2024Q1 sbig Deferred Financial Advisory Fees Current
DeferredFinancialAdvisoryFeesCurrent
1000000 usd
CY2023Q4 sbig Deferred Financial Advisory Fees Current
DeferredFinancialAdvisoryFeesCurrent
1000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
701000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
382000 usd
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2041000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1951000 usd
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
8000000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
609000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
7391000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2900000 usd
CY2024Q2 sbig Estimated Fair Value Of Warrants
EstimatedFairValueOfWarrants
54400000 usd
CY2023Q4 sbig Estimated Fair Value Of Warrants
EstimatedFairValueOfWarrants
3200000 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
48000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-64000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
51000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
89000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6612000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7214000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13086000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14371000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6612000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7214000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13086000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14371000 usd
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
252000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
273000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
273000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
333000 usd
sbig Contract With Customer Assets Expense Deferred Including Opening Balance
ContractWithCustomerAssetsExpenseDeferredIncludingOpeningBalance
82000 usd
CY2023 sbig Contract With Customer Assets Expense Deferred Including Opening Balance
ContractWithCustomerAssetsExpenseDeferredIncludingOpeningBalance
165000 usd
sbig Contract With Customer Assets Amounts Expensed During The Year
ContractWithCustomerAssetsAmountsExpensedDuringTheYear
-103000 usd
CY2023 sbig Contract With Customer Assets Amounts Expensed During The Year
ContractWithCustomerAssetsAmountsExpensedDuringTheYear
-225000 usd
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
252000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
273000 usd
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1525175 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.05 pure
CY2022Q2 sbig Common Stock Additional Capital Shares Reserved For Future Issuance
CommonStockAdditionalCapitalSharesReservedForFutureIssuance
1332986 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
2266988 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.05 pure
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2271894 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.57
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2244102 shares
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M21D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
8892 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.26
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2263002 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.57
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2263002 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M25D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.57
CY2024Q2 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
18000 usd
us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
35000 usd
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
30000 usd
us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
61000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2263002 usd
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0 usd
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P98M
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2941000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
341000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
99000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2729000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
225000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3070000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
324000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
161000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
93000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
321000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
226000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
321000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
226000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
175000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
235000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2781000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
165000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P88M12D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P22M27D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0905 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0683 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
290000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
595000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
592000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
504000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
510000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1767000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4258000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1188000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3070000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
2000000 usd
CY2023Q2 sbig Offset Related To Operating Expenses
OffsetRelatedToOperatingExpenses
600000 usd
sbig Fair Value Of Public Warrants
FairValueOfPublicWarrants
54400 usd
sbig Sponsor Escrow Agreement Sponsor Earnout Shares
SponsorEscrowAgreementSponsorEarnoutShares
1000000 shares
CY2024Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12
CY2024Q2 sbig Authorized Capital Stock
AuthorizedCapitalStock
350000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46148026 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46148026 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41402847 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41402847 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-647000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2028000 usd
us-gaap Net Income Loss
NetIncomeLoss
-230000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4290000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45721610 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31489803 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45576941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29159766 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2024Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
94000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
190000 usd
CY2023Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
131000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
289000 usd
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
usd
CY2023Q2 us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
usd
us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29159766 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31489803 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45576941 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45721610 shares
CY2024Q2 sbig Shares Issued Shares Share Based Payment Arrangement Vested
SharesIssuedSharesShareBasedPaymentArrangementVested
usd
sbig Shares Issued Shares Share Based Payment Arrangement Vested
SharesIssuedSharesShareBasedPaymentArrangementVested
usd
us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
usd
us-gaap Other Noncash Expense
OtherNoncashExpense
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
usd
sbig Increase Decrease In Contract With Customer Liability Payroll Tax Credits
IncreaseDecreaseInContractWithCustomerLiabilityPayrollTaxCredits
usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Stock Issued1
StockIssued1
usd
us-gaap Notes Issued1
NotesIssued1
usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29159766 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31489803 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45576941 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45721610 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001801602
dei No Trading Symbol Flag
NoTradingSymbolFlag
true

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
sbig-20240630_cal.xml Edgar Link unprocessable
0001213900-24-068301-index-headers.html Edgar Link pending
0001213900-24-068301-index.html Edgar Link pending
0001213900-24-068301.txt Edgar Link pending
0001213900-24-068301-xbrl.zip Edgar Link pending
ea0209813-10q_springbig.htm Edgar Link pending
ea020981301ex31-1_springbig.htm Edgar Link pending
ea020981301ex31-2_springbig.htm Edgar Link pending
ea020981301ex32-1_springbig.htm Edgar Link pending
ea020981301ex32-2_springbig.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
ea0209813-10q_springbig_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbig-20240630.xsd Edgar Link pending
Show.js Edgar Link pending
sbig-20240630_def.xml Edgar Link unprocessable
sbig-20240630_lab.xml Edgar Link unprocessable
sbig-20240630_pre.xml Edgar Link unprocessable